show video detail
CEOLIVE Executive Interview | Thomas Paulson, CFO of NovaBay Pharma (NYSE MKT: NBY)
- Published_at:2013-06-24
- Category:People & Blogs
- Channel:Mike Elliott
- tags:
- description: In this CEOLIVE Executive Interview we speak to Mr. Thomas Paulson, CFO of NovaBay Pharmaceuticals (NYSE MKT: NBY). NovaBay Pharmaceuticals is a biotechnology company focused on addressing the large unmet therapeutic needs of the global, topical anti-infective market with auriclosene. The Company's four core business units -- DermaBay, UroBay, EyeBay and MediBay -- are developing products in dermatology, urology, ophthalmology, and wound care areas. Disclosure: Neither CEOLIVE.TV or any of its principals currently owns or plan to own within 72 hours of publication any shares of the stocks mentioned in this video. For a full disclaimer please visit, ceolive.tv/disclaimer.
| ranked in date | views | likes | Comments | ranked in country (#position) |
|---|---|---|---|---|
| 2013-07-03 | 23,418 | 3 | 0 |
( ,#26)
( ,#19)
|
| 2013-07-04 | 26,675 | 3 | 3 |
(,#70)
|
